Insider · CIK 0001746808
Stephen Connelly
Files at EQ (Equillium, Inc.). First filing Jun 5, 2026, latest Jun 5, 2026.
In brief
Stephen Connelly files SEC Form 4 as director and president at EQ (Equillium, Inc.). Since Jun 5, 2026, Stephen Connelly has reported 0 open-market buys worth $0 and 1 open-market sell worth $724k, the latest filed on Jun 5, 2026.
A track record needs three past buys with six months of prices behind them; Stephen Connelly has 0, so none is measured yet.
The newest scored trade: sold $724k of EQ on Jun 4, 2026, filed Jun 5, 2026, scored 61 (notable). In the last 12 months: 0 buys worth $0 and 1 sell worth $724k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
EQ: Equillium, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 61Notable | Equillium, Inc. | $724k 230,975 shares | -23% | +993% from low0% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jun 5, 2026 | EQ Equillium, Inc. | 30,975 0.05% of outstanding | $91k | Jun 5, 2026 | $633k |
| Jun 4, 2026 | EQ Equillium, Inc | 200,000 0.32% of outstanding | $633k | Jun 4, 2026 | none |
Transactions
Every row this insider has filed, 18 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 4, 2026 | EQ Equillium, Inc. | SOpen-market sale Common Stock | -200,000 | $3.16 | $633k | 793,000 | Jun 5, 2026 |
| Jun 5, 2026 | EQ Equillium, Inc. | SOpen-market sale Common Stock | -30,975 | $2.94 | $91k | 762,025 | Jun 5, 2026 |
| Jan 7, 2026 | EQ Equillium, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +1,150,000 | $0.00 | $0 | 1,150,000 | Jan 9, 2026 |
| Aug 29, 2025 | EQ Equillium, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +1,025,000 | $0.00 | $0 | 1,025,000 | Sep 3, 2025 |
| Feb 14, 2025 | EQ Equillium, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +90,000 | - | - | 90,000 | Feb 19, 2025 |
| Feb 14, 2025 | EQ Equillium, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -90,000 | - | - | 0 | Feb 19, 2025 |
| Feb 14, 2025 | EQ Equillium, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +52,500 | - | - | 52,500 | Feb 19, 2025 |
| Feb 14, 2025 | EQ Equillium, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -52,500 | - | - | 0 | Feb 19, 2025 |
| Feb 14, 2025 | EQ Equillium, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +100,000 | - | - | 100,000 | Feb 19, 2025 |
| Feb 14, 2025 | EQ Equillium, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -100,000 | - | - | 0 | Feb 19, 2025 |
| Feb 14, 2025 | EQ Equillium, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +42,534 | - | - | 42,534 | Feb 19, 2025 |
| Feb 14, 2025 | EQ Equillium, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -42,534 | - | - | 0 | Feb 19, 2025 |
| Feb 14, 2025 | EQ Equillium, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +125,000 | - | - | 125,000 | Feb 19, 2025 |
| Feb 14, 2025 | EQ Equillium, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -125,000 | - | - | 0 | Feb 19, 2025 |
| Feb 14, 2025 | EQ Equillium, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +175,000 | - | - | 175,000 | Feb 19, 2025 |
| Feb 14, 2025 | EQ Equillium, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -175,000 | - | - | 0 | Feb 19, 2025 |
| Jan 2, 2025 | EQ Equillium, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +175,000 | $0.00 | $0 | 175,000 | Jan 6, 2025 |
| Jan 2, 2024 | EQ Equillium, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +175,000 | $0.00 | $0 | 175,000 | Jan 3, 2024 |
Questions about Stephen Connelly
Answered from the filings on this page, as of the latest one.
Is Stephen Connelly buying or selling?
In the last 12 months Stephen Connelly reported 0 open-market buys worth $0 and 1 open-market sell worth $724k on SEC Form 4; the latest was sold $724k of EQ on Jun 4, 2026. Grants, option exercises and tax withholding are not counted.
How did Stephen Connelly's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Stephen Connelly has 0.
Where does Stephen Connelly file Form 4?
Stephen Connelly has filed Form 4 at EQ (Equillium, Inc.) as Chief Scientific Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.